Danazol Induced Thrombocytopenia.
A patient developed severe thrombocytopenia and purpura upon initiating danazol treatment for an ovarian cyst, with symptoms recurring upon rechallenge, indicating drug-induced immune thrombocytopenic purpura.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This case report describes a 34-year-old woman treated with danazol 400 mg/day for a presumed endometrial cyst/left ovarian cyst, who developed gingival bleeding and purpura the day after a total dose of only 600 mg. Laboratory testing led to a diagnosis of immune thrombocytopenic purpura, and her platelet count increased after methylprednisolone treatment, but thrombocytopenia recurred rapidly when danazol was re-administered, with platelets dropping to 5,000/mm3. A limitation is that the evidence is confined to a single patient and a temporal association without broader mechanistic or comparative assessment. Relevance to endometriosis: the cyst was clinically diagnosed as an endometrial cyst and later histologically confirmed as an endometrial cyst, making the case directly related to endometriosis/endometrioma.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (4)
- DANAZOL‐INDUCED THROMBOCYTOPENIA via openalex
- Laparoscopic evaluation of the onset and progression of endometriosis via openalex
- W2016782194 via openalex
- W2467614312 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:46.468712+00:00